About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us

   About Us: Executive Team

 
 

3/28/2012 - Daxor Corporation Announces Year End 2011 Earnings

  

3/23/2012 - Daxor Announces That Shertech Pharmacy Acquires 2nd BVA-100 Blood Volume Analyzer

  

3/9/2012 - Daxor Announces Filing of Two Additional Patents for Updated Automated Blood Analyzer

  
 

______________________

 
     
  2011 Year End Earnings  
  2011 Form 10-K  
  September 2011 Form 10-Q  
  2011 Proxy Statement  
  DAXOR Corporation Newsletter; Issue 1, March 2010  
  2010 Annual Report  
 
    Menu Options

Home Page

Medical Advisory Board

Board of Directors

Contact Us

Company

Careers

 

 

 

 

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

 

Joseph Feldschuh, M.D., President and CEO

Dr. Feldschuh has been President of DAXOR since 1974. He is on the staff of Montefiore Hospital and Medical Center. From 1966 to 1983, Dr. Feldschuh was Director of the Cardiac Metabolic Laboratory at Metropolitan Hospital. He has been a Clinical Associate Professor at Cornell Medical School. He performed the basic research at the College of Physicians and Surgeons (Columbia University) on the measurement and prediction of normal human blood volume. He is the co-inventor of the Blood Volume Analyzer and the inventor of the quantitative injection kit for the BVA-100. He is Board Certified in Cardiology and Internal Medicine.

Stephen Feldschuh, Vice President, Marketing and Development

Stephen Feldschuh earned his undergraduate degree in Business Administration (BS) from Boston University in 1988. He also has his Master's degree (MBA) in Finance from Baruch College, 1997. After graduating college, he worked for Bear Stearns & Merrill Lynch as a Commodity Broker & Futures Trader. From 1992 to 1997, he joined DAXOR as Operations Manager with various responsibilities including Quality Assurance of the laboratory. From mid 1997 to 1999, Mr. Feldschuh was a financial analyst doing mergers and acquisitions in the staffing industry for Headway Corporate Resources. Mr. Feldschuh then worked for Delia's Inc. as a Financial Controller until 2001 when he rejoined the DAXOR Corporation.

David Frankel, Chief Financial Officer

David Frankel earned his Bachelors Degree (BBA) in Public Accounting from Hofstra University and is licensed as a CPA in New York. Prior to joining DAXOR, David worked in the staffing industry as a Controller at Strategic Workforce Solutions and Charles River Computers and was at Winston Resources for five years, serving as Principal Financial Officer from May 1993 through August 1995. David was the Controller of Stern Stewart, a multi-office International Financial Consulting Firm from March 1997 through August 2004.

Diane Meegan, Corporate Secretary

Diane Meegan joined DAXOR Corporation in February 2002 as the Senior Executive Assistant to the CEO and President. Ms. Meegan is currently the Corporate Secretary. Ms. Meegan served as the Official Executive Assistant to the CEO of Newbridge Securities, a wholly owned subsidiary of Citigroup, for 13 years. For 4 years, she served as a member of their Problem Review Board. In the past 2 years, she served as the Executive Assistant to the Head of Operations at Instinet Clearing Services.

Gary Fischman, Ph.D., Vice President, R&D

Gary Fischman obtained his Doctor of Podiatric Medicine from the Pennsylvania College of Podiatric Medicine and his Ph.D. in Pathology from Thomas Jefferson University. He joined DAXOR in May 1998 and he comes from a background of teaching and research. He is a diplomate of the American Academy of Pain Management.


© 2012 DAXOR Corporation. All Rights Reserved.